Tariff Rate Comparison
Pharmaceutical Ingredients (API)| Rate Type |  Indiabilateral |  JapanSave 3.0pp vs highestbilateral |
|---|---|---|
| MFN Base RateMost Favored Nation tariff | 2.00% | 2.00% |
| Section 122Emergency surcharge (expires ~Jul 24, 2026) | 0.00% | 0.00% |
| Section 232Steel & aluminum tariff | N/A | N/A |
| Section 301China-only additional tariff | N/A | N/A |
| Bilateral DealNegotiated rate replaces S122 | 18.00% | 15.00% |
| Total Effective Rate | 20.00% | 17.00% |
Rate Comparison by Product Category
| Product | India | Japan | Savings ($10K) |
|---|---|---|---|
| pharmaceutical ingredients | 20.0% | 17.0% | $317 |
| consumer electronics | 19.5% | 16.5% | $317 |
| auto parts components | 28.0% | 28.0% | $0 |
| industrial machinery | 20.0% | 17.0% | $317 |
| chemicals industrial compounds | 21.5% | 18.5% | $317 |
Trade Agreement Status
India has a bilateral deal with the US at 18% (replaces the standard Section 122 rate). Japan has a bilateral deal with the US at 15% (replaces the standard Section 122 rate). For products under Section 232 national security tariffs, the bilateral deal or Section 122 rate does not apply — S232 rates govern instead. China-origin goods additionally face Section 301 tariffs that stack on top of all other duties, making trade agreement status a defining factor in the total tariff burden.
When to Source from Each Country
Source from India when importing auto parts components, where its tariff rates are more competitive. Source from Japan for pharmaceutical ingredients and consumer electronics, where it carries the tariff advantage. Beyond tariff rates, factor in lead times, minimum order quantities, quality standards, and freight costs — the total landed cost comparison may shift depending on shipment volume and logistics conditions.
Full Landed Cost — $10,000 Shipment
Pharmaceutical Ingredients (API)IndiaFull Landed Cost Breakdown
Based on a $10,000 ocean shipment (FOB value)
JapanFull Landed Cost Breakdown
Based on a $10,000 ocean shipment (FOB value)
Savings Analysis
On a $10,000 shipment of pharmaceutical ingredients, importing from Japan saves $317 in duties compared to India — a 15% reduction in total import costs. Japan incurs $1,794 in duties on the $10,000 shipment, while India incurs $2,110. This difference compounds across larger order volumes and is a key factor in supplier selection decisions for importers sourcing pharmaceutical ingredients.
Frequently Asked Questions
The total effective tariff rate on pharmaceutical ingredients is 20% from India and 17% from Japan under current 2026 tariff policy. These rates include the MFN base rate, applicable Section 122 surcharge or bilateral deal rate, Section 232 duties for covered products, and Section 301 tariffs for Chinese goods. Use the CalcMyTariff.com calculator above to enter your specific invoice value and shipping details for a precise landed cost breakdown.
India has a bilateral trade agreement with the US under which a negotiated rate of 18% applies to imports, replacing the standard Section 122 rate. This deal provides more predictable tariff treatment than countries without formal agreements, though its legal durability following the IEEPA ruling remains subject to ongoing policy developments.
Japan has a bilateral trade deal with the US at a negotiated rate of 15%, which replaces the Section 122 rate for imports from Japan. This creates a differentiated tariff structure compared to non-deal countries.
Japan is cheaper for consumer electronics with a 16.5% total tariff rate, compared to 19.5% from India. On a $10,000 shipment, this 3% rate difference saves $300 in duties when sourcing from Japan.
Section 122, enacted in February 2026 for up to 150 days, imposes a global surcharge on most US imports. India's bilateral deal rate of 18% replaces the standard Section 122 rate. Japan's bilateral deal rate of 15% replaces Section 122. Note that Section 122 is scheduled to expire on July 24, 2026 — importers should model both current and post-expiry scenarios when planning shipments.